# MarketBeat

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/marketbeat
Canonical HTML page: https://getyourbrief.com/entity/marketbeat

## Timeline

- **2026-08-22**: Wall Street Zen issues opposing ratings — Downgraded T1 Energy from Sell to Strong Sell and upgraded SM Energy from Buy to Strong Buy.
- **2026-08-15**: Wall Street Zen upgrades BKKT and DEI — Wall Street Zen upgraded Bakkt and Douglas Emmett from sell to hold in research notes issued Saturday morning.
- **2026-08-15**: Wall Street Zen upgrades BKKT and DEI — Wall Street Zen upgraded Bakkt and Douglas Emmett from sell to hold in research notes issued Saturday morning.
- **2026-08-12**: Benchmark cuts BKKT target — Benchmark reduced its Bakkt price target from $19.00 to $12.00 while maintaining a buy rating.
- **2026-08-12**: Benchmark cuts BKKT target — Benchmark reduced its Bakkt price target from $19.00 to $12.00 while maintaining a buy rating.
- **2026-08-12**: T1 Energy earnings and BTIG target move — T1 Energy reported a -$0.09 EPS loss; BTIG raised its T1 target from $8.00 to $9.00 with a Buy rating.
- **2026-08-10**: Bakkt reports quarterly results — Bakkt announced EPS of $1.94 and revenue of $170.15 million, missing revenue consensus of $373.27 million.
- **2026-08-10**: Bakkt reports quarterly results — Bakkt announced EPS of $1.94 and revenue of $170.15 million, missing revenue consensus of $373.27 million.
- **2026-08-10**: Truist raises SM Energy target — Increased price target from $37.00 to $43.00 and maintained a Buy rating.
- **2026-08-08**: Wall Street Zen cuts STAG and ZVIA to Sell — Wall Street Zen downgraded both Stag Industrial and Zevia PBC from hold to sell in weekend research notes.
- **2026-08-07**: Cantor Fitzgerald raises DEI target — Cantor Fitzgerald raised its Douglas Emmett target price from $12.00 to $13.00 with a neutral rating.
- **2026-08-07**: Cantor Fitzgerald raises DEI target — Cantor Fitzgerald raised its Douglas Emmett target price from $12.00 to $13.00 with a neutral rating.
- **2026-08-05**: ZVIA reports Q2 results — Zevia PBC reported EPS of -$0.03, hitting consensus, and revenue of $45.00 million versus a $44.21 million estimate.
- **2026-08-05**: SM Energy quarterly results — SM Energy reported $2.19 earnings per share for the quarter.
- **2026-08-04**: Douglas Emmett reports earnings — Douglas Emmett reported quarterly EPS of negative $0.02.

## Recent coverage (20 stories, network-wide)

### 5 Manufacturing Stocks See Highest Volume: Semiconductor Supply Chain Leads
2026-08-24 04:00:33 · Sector: supply · Sentiment: Neutral · Impact: 5/10 · Sources: 2

A MarketBeat screener for August 23, 2026 ranks Taiwan Semiconductor, Applied Materials, and Fabrinet among the top-volume manufacturing names, signaling capital flows into semiconductor production capacity. Honeywell Aerospace and Phillips 66 round out the list, tying the signal to aerospace and energy supply chains.
Full story: https://getsupplybrief.com/story/manufacturing-stocks-volume-semiconductor-supply-chain-aug-2026

### 19 High-Volume Stocks: Crypto Miners, Airlines, and a 2X TSLA ETF
2026-08-24 04:00:12 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

A MarketBeat volume scan for August 23, 2026 flags 19 names across manufacturing, penny, and mid-cap categories, including semiconductor heavyweights, six crypto miners, two airlines, and a leveraged TSLA ETF. The mix points to broad speculative and cyclical positioning rather than a single sector theme.
Full story: https://getfinancebrief.com/story/high-volume-stock-screener-crypto-airlines-leveraged-tsla-aug-2026

### T1 Energy Cut to Strong Sell at $4.45; SM Energy Upgraded to Strong Buy
2026-08-24 03:19:53 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wall Street Zen issued divergent ratings on two energy names, cutting T1 Energy to Strong Sell while lifting SM Energy to Strong Buy. T1 trades at $4.45 with negative P/E and 3.5 D/E, while SM offers a 7.35 P/E and 0.85 D/E. The split highlights a rotation from leveraged loss-makers to cash-flow-positive mid-cap energy.
Full story: https://getfinancebrief.com/story/t1-energy-strong-sell-sm-energy-strong-buy-wall-street-zen-2026-08

### 3 Cyber Stocks Lead Aug 21 Volume: PANW +1.8%, CRWD +2.3%, FTNT +0.9%
2026-08-23 23:57:45 · Sector: cyber · Sentiment: Neutral · Impact: 5/10 · Sources: 2

A dollar-volume screen put Palo Alto Networks, CrowdStrike, and Fortinet atop the cybersecurity group on August 21 — a liquidity snapshot showing investor conviction concentrating in scaled, AI-native security platforms. The same day, PANW and CRWD both traded higher, with CRWD's gen-AI workload security noted as a key differentiator.
Full story: https://getcyberbrief.com/story/cyber-stocks-panw-crwd-ftnt-august-21-volume

### 3 Blockchain Stocks Top Volume: BTDR -1.2%, CORZ +4.1% as BTC ~$118K
2026-08-23 23:57:35 · Sector: crypto · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Bitdeer, Core Scientific, and Figure led blockchain-stock dollar volume on August 21, with CORZ up 4.1% while BTDR slipped 1.2% as bitcoin held near $118,450. The screen highlights how mining equities trade as liquid, leveraged proxies for BTC.
Full story: https://getcryptobrief.com/story/blockchain-stocks-btdr-corz-figure-august-21-volume

### 5 Value Stocks to Watch: MRNA, QQQ, Intel, Nebius, SpaceX
2026-08-19 21:41:52 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

MarketBeat's August 19 high-volume value screen names Moderna, QQQ, Intel, Nebius, and SpaceX, while a large-cap screen adds SanDisk and Micron. The list highlights where dollar volume concentrated, but classifications include an ETF and a private company, so investors should validate the data before acting.
Full story: https://getfinancebrief.com/story/value-stocks-aug-19-marketbeat-mrna-intc-nbis

### Moderna Leads 2 MarketBeat Watchlists Among 5 Value Stocks
2026-08-19 21:41:40 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Moderna appears on both MarketBeat's value and large-cap high-volume screens on August 19, underscoring unusual liquidity and renewed biotech interest despite a post-COVID valuation reset. The mRNA pipeline spans respiratory, latent, and public health vaccines, setting up multiple clinical catalysts.
Full story: https://getbiobrief.com/story/moderna-marketbeat-value-bio-aug-2026

### Applied Digital Falls 8.6% to $28.51 as Analyst Targets Split
2026-08-19 00:18:04 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Applied Digital shares slid 8.6% to $28.51 despite a Moderate Buy consensus and an average target of $68.15. The decline highlights a growing divide between sell-side optimism and trader concerns about negative earnings and elevated leverage.
Full story: https://getfinancebrief.com/story/applied-digital-8-6-percent-drop-august-2026

### Applied Digital Drops 8.6% as AI Datacenter Bets Face $8.3B Test
2026-08-19 00:17:49 · Sector: ai · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Applied Digital's 8.6% drop to $28.51, paired with a 5.1% fall in quantum peer Rigetti, signals cooling sentiment toward AI-adjacent infrastructure stocks after APLD's July earnings miss. High beta and negative EPS are forcing AI investors to reassess execution risk.
Full story: https://getaibrief.com/story/apld-8-6-percent-drop-ai-infrastructure-reckoning

### Bakkt's $341M Market Cap Gets Hold Upgrade; Revenue Misses by 54%
2026-08-17 01:01:48 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wall Street Zen's sell-to-hold upgrade for Bakkt comes as the stock trades at $7.66 with a $341.53 million market cap. The move follows a 54% revenue miss and a director's $783,000 insider buy, leaving analysts divided on whether this is a bottom or a value trap.
Full story: https://getfinancebrief.com/story/bakkt-hold-upgrade-wall-street-zen-finance

### Bakkt Upgraded to Hold as BKKT Sits 85% Below Its $49.79 High
2026-08-17 01:01:34 · Sector: crypto · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Crypto platform Bakkt's sell-to-hold upgrade masks a brutal year: shares at $7.66 are down 85% from $49.79. A director's insider buy and an extreme beta of 5.91 frame the risk-reward for Web3 investors watching custody and exchange infrastructure.
Full story: https://getcryptobrief.com/story/bakkt-upgrade-hold-85-percent-below-high

### KTCC 40.7% Institutional Ownership vs SMIT -0.21 Beta: Microcap Risk/Reward
2026-08-16 20:20:40 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

A head-to-head comparison of two small-cap tech names reveals a sharp risk divergence: Key Tronic's 1.19 beta and 40.7% institutional backing contrast with Schmitt Industries' rare negative -0.21 beta and 17.1% insider ownership. Investors must decide between a contract manufacturer with above-market volatility and a niche instrumentation play with inverse correlation to the S&P 500.
Full story: https://getfinancebrief.com/story/ktcc-smit-beta-ownership-contrast

### Renuvion Maker Apyx Drops 1.8% to $4.38 Despite Q1 Revenue Beat
2026-08-13 02:42:20 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2

For healthcare and medical device stakeholders, Apyx Medical's Q1 revenue of $12.49 million beat consensus by $1.96 million, yet the stock fell 1.8% to $4.38. The decline on 60% below-average volume suggests limited conviction, while analysts maintain a moderate buy rating and $6.50 target. The company's strong liquidity ratios contrast with its negative net margin and return on equity.
Full story: https://gethealthbrief.com/story/apyx-medical-revenue-beat-stock-drop-health

### Apyx Medical EPS Beats by $0.06, Stock Still Slides 1.8% to $4.38
2026-08-13 02:42:10 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2

For biotech and pharma investors, Apyx Medical's Q1 loss of $0.05 per share beat consensus by $0.06, but the stock fell 1.8% to $4.38 on low volume. Mixed analyst ratings and a $6.50 consensus target raise questions about whether the small-cap device maker can convert clinical and operational beats into stock appreciation. Institutional repositioning signals ongoing evaluation of the company's commercial ramp.
Full story: https://getbiobrief.com/story/apyx-medical-q1-eps-beat-stock-slide-bio

### 5 Blockchain Stocks To Watch as Core Scientific, Bitdeer Lead Volume
2026-08-13 01:52:16 · Sector: crypto · Sentiment: Neutral · Impact: 5/10 · Sources: 2

MarketBeat's screener surfaced five blockchain equities with the highest dollar volume on July 25, 2026: Core Scientific, Bitdeer, Globant, Figure Technology Solutions, and Digi Power X. For crypto-native investors, these public names offer indirect exposure to mining, infrastructure, and blockchain services without directly holding BTC. The list underscores where liquidity is rotating among blockchain-linked stocks amid continued volatility.
Full story: https://getcryptobrief.com/story/blockchain-stocks-to-watch-july-25-2026

### STAG Downgraded to Sell as Price Sits 38% Below $50.50 Target
2026-08-13 00:19:12 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wall Street Zen cut Stag Industrial to sell, putting a fresh bearish tilt on a REIT whose shares opened at $36.68 versus a $50.50 consensus target. The same firm also downgraded Zevia PBC as its major shareholder trimmed a 15.87% stake.
Full story: https://getfinancebrief.com/story/stag-industrial-wall-street-zen-sell-downgrade

### Weave's $8.33 Price Target Points to 27.58% SaaS Upside
2026-08-12 20:31:35 · Sector: saas · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Weave Communications, a healthcare SaaS and payments vendor, beats Surgical Science Sweden on six of nine factors. Its $8.33 consensus target and 86.8% institutional ownership highlight investor confidence in its SMB healthcare platform.
Full story: https://getsaasbrief.com/story/weave-communications-saas-price-target-upside

### Weave's $8.33 Target vs Surgical Science: 27.58% Upside
2026-08-12 20:31:30 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2

A head-to-head survey gives Weave Communications a stronger rating and 27.58% upside over Surgical Science Sweden, but the two health companies serve very different markets: patient engagement software versus surgical simulation.
Full story: https://gethealthbrief.com/story/weave-surgical-science-health-it-comparison

### Graphite Electrode Maker EAF Jumps 2.6% to $5.91 Amid Supply Chain Headwinds
2026-08-12 17:11:16 · Sector: supply · Sentiment: Neutral · Impact: 5/10 · Sources: 2

GrafTech's 2.6% daily rise obscures deeper weakness: analyst downgrades, an EPS miss of $0.80, and a market cap of just $154M. For supply chain professionals, the move is a reminder to watch graphite electrode pricing and supplier financial health.
Full story: https://getsupplybrief.com/story/graftech-eaf-supply-chain-2-6-percent-rise-july-2026

### Entera Bio Down 0.6% as $9.00 Analyst Target Highlights Split
2026-08-12 16:26:13 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Shares of Entera Bio slipped 0.6% to $1.54 on 78% below-average volume, but analysts remain deeply split: HC Wainwright reiterates buy while Weiss Ratings maintains a sell. The $9.00 consensus target implies roughly 484% upside for the $75.91M microcap biotech.
Full story: https://getbiobrief.com/story/entera-bio-down-06-analyst-target-9

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.